Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

In recent years, neoadjuvant treatment trials have shown that breast cancer subtypes identified on the basis of genomic and/or molecular signatures exhibit different response rates and recurrence outcomes, with the implication that subtype-specific treatment approaches are needed. Estrogen receptor-...

Full description

Bibliographic Details
Main Authors: Ella F. Jones, Deep K. Hathi, Rita Freimanis, Rita A. Mukhtar, A. Jo Chien, Laura J. Esserman, Laura J. van’t Veer, Bonnie N. Joe, Nola M. Hylton
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
breast cancer
estrogen receptor (ER)
neoadjuvant therapy
mammography
MRI
PET
Online Access:https://www.mdpi.com/2072-6694/12/6/1511

Internet

https://www.mdpi.com/2072-6694/12/6/1511

Similar Items